Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 232

1.

Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) study.

Sheffer AL, Silverman M, Woolcock AJ, Díaz PV, Lindberg B, Lindmark B.

Ann Allergy Asthma Immunol. 2005 Jan;94(1):48-54.

PMID:
15702816
2.

A single high dose of inhaled corticosteroids: a possible treatment of asthma exacerbations.

Leuppi JD, Downie SR, Salome CM, Jenkins CR, Woolcock AJ.

Swiss Med Wkly. 2002 Jan 12;132(1-2):7-11.

PMID:
11901445
3.

Risk factors for onset and remission of atopy, wheeze, and airway hyperresponsiveness.

Xuan W, Marks GB, Toelle BG, Belousova E, Peat JK, Berry G, Woolcock AJ.

Thorax. 2002 Feb;57(2):104-9.

4.

Analysis of adherence to peak flow monitoring when recording of data is electronic.

Reddel HK, Toelle BG, Marks GB, Ware SI, Jenkins CR, Woolcock AJ.

BMJ. 2002 Jan 19;324(7330):146-7. No abstract available.

5.

Effect of budesonide on the perception of induced airway narrowing in subjects with asthma.

Salome CM, Reddel HK, Ware SI, Roberts AM, Jenkins CR, Marks GB, Woolcock AJ.

Am J Respir Crit Care Med. 2002 Jan 1;165(1):15-21.

PMID:
11779724
6.

Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma.

Leuppi JD, Salome CM, Jenkins CR, Koskela H, Brannan JD, Anderson SD, Andersson M, Chan HK, Woolcock AJ.

Eur Respir J. 2001 Sep;18(3):444-50.

7.

The burden of asthma in Australia.

Woolcock AJ, Bastiampillai SA, Marks GB, Keena VA.

Med J Aust. 2001 Aug 6;175(3):141-5.

PMID:
11548080
8.

Asthma in preschool children: prevalence and risk factors.

Haby MM, Peat JK, Marks GB, Woolcock AJ, Leeder SR.

Thorax. 2001 Aug;56(8):589-95.

9.

Eosinophilia, interleukin-5, and tumour necrosis factor-alpha in asthmatic children.

Hughes JM, Rimmer SJ, Salome CM, Hodge L, Liu-Brennan D, Woolcock AJ, Armour CL.

Allergy. 2001 May;56(5):412-8.

PMID:
11350304
10.

Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids.

Leuppi JD, Salome CM, Jenkins CR, Anderson SD, Xuan W, Marks GB, Koskela H, Brannan JD, Freed R, Andersson M, Chan HK, Woolcock AJ.

Am J Respir Crit Care Med. 2001 Feb;163(2):406-12.

PMID:
11179114
11.

Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness.

Schachter LM, Salome CM, Peat JK, Woolcock AJ.

Thorax. 2001 Jan;56(1):4-8.

12.

Optimal asthma control, starting with high doses of inhaled budesonide.

Reddel HK, Jenkins CR, Marks GB, Ware SI, Xuan W, Salome CM, Badcock CA, Woolcock AJ.

Eur Respir J. 2000 Aug;16(2):226-35. Erratum in: Eur Respir J 2000 Sep;16(3):579.

13.

The effect of insecticide aerosols on lung function, airway responsiveness and symptoms in asthmatic subjects.

Salome CM, Marks GB, Savides P, Xuan W, Woolcock AJ.

Eur Respir J. 2000 Jul;16(1):38-43.

15.

Lung function growth and its relation to airway hyperresponsiveness and recent wheeze. Results from a longitudinal population study.

Xuan W, Peat JK, Toelle BG, Marks GB, Berry G, Woolcock AJ.

Am J Respir Crit Care Med. 2000 Jun;161(6):1820-4.

PMID:
10852751
16.

What is the relationship between airway hyperresponsiveness and atopy?

Woolcock AJ, Peat J.

Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 2):S215-7. Review. No abstract available.

PMID:
10712378
17.

Family patterns of asthma, atopy and airway hyperresponsiveness: an epidemiological study.

Gray L, Peat JK, Belousova E, Xuan W, Woolcock AJ.

Clin Exp Allergy. 2000 Mar;30(3):393-9.

PMID:
10691898
18.

The message from the World Asthma Meeting. The Working Groups of the World Asthma Meeting, held in Barcelona, Spain, December 9-13, 1998.

Sterk PJ, Buist SA, Woolcock AJ, Marks GB, Platts-Mills TA, von Mutius E, Bousquet J, Frew AJ, Pauwels RA, Aït-Khaled N, Hill SL, Partridge MR.

Eur Respir J. 1999 Dec;14(6):1435-53. Review.

19.

Opportunities for Japanese-Australian cooperation in asthma research.

Woolcock AJ.

Respirology. 1999 Dec;4(4):409-11. Review. No abstract available.

PMID:
10612577
20.

Do subjects with asthma have greater perception of acute bronchoconstriction than smokers with airflow limitation?

Massasso DH, Salome CM, King GG, Seale JP, Woolcock AJ.

Respirology. 1999 Dec;4(4):393-9.

PMID:
10612574
21.

Inhaler technology: new concepts for the millennium.

Woolcock AJ.

Postgrad Med. 1999 Dec;106(7 Suppl):18-21. doi: 10.3810/pgm.12.1999.suppl2.9. Review.

PMID:
19667497
22.

Perception of bronchodilation in subjects with asthma and smokers with airflow limitation.

Massasso DH, Salome CM, King GG, Seale JP, Woolcock AJ.

Respirology. 1999 Jun;4(2):117-24.

PMID:
10382229
24.

Persistent cough: is it asthma?

Faniran AO, Peat JK, Woolcock AJ.

Arch Dis Child. 1998 Nov;79(5):411-4.

25.

Exhaled nitric oxide measurements in a population sample of young adults.

Salome CM, Roberts AM, Brown NJ, Dermand J, Marks GB, Woolcock AJ.

Am J Respir Crit Care Med. 1999 Mar;159(3):911-6.

PMID:
10051272
27.

Difficult asthma.

Barnes PJ, Woolcock AJ.

Eur Respir J. 1998 Nov;12(5):1209-18. Review.

28.

Differences in airway closure between normal and asthmatic subjects measured with single-photon emission computed tomography and technegas.

King GG, Eberl S, Salome CM, Young IH, Woolcock AJ.

Am J Respir Crit Care Med. 1998 Dec;158(6):1900-6.

PMID:
9847284
29.

Questionnaire items that predict asthma and other respiratory conditions in adults.

Bai J, Peat JK, Berry G, Marks GB, Woolcock AJ.

Chest. 1998 Nov;114(5):1343-8.

PMID:
9824012
30.

Pitfalls in processing home electronic spirometric data in asthma.

Reddel HK, Ware SI, Salome CM, Jenkins CR, Woolcock AJ.

Eur Respir J. 1998 Oct;12(4):853-8.

31.

Standardization of ambulatory peak flow monitoring: the importance of recent beta2-agonist inhalation.

Reddel HK, Ware SI, Salome CM, Marks GB, Jenkins CR, Woolcock AJ.

Eur Respir J. 1998 Aug;12(2):309-14.

32.

Severity of chronic asthma.

Woolcock AJ, Dusser D, Fajac I.

Thorax. 1998 Jun;53(6):442-4. No abstract available.

33.

Effect of drugs on small airways.

Woolcock AJ.

Am J Respir Crit Care Med. 1998 May;157(5 Pt 2):S203-7. Review.

PMID:
9606322
34.

Clinical assessment of patients.

Godard P, Clark TJ, Busse WW, Woolcock AJ, Sterk P, Aubier M, Pride N, Postma D.

Eur Respir J Suppl. 1998 Mar;26:2S-5S. Review. No abstract available.

PMID:
9585870
35.

Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children.

Hodge L, Salome CM, Hughes JM, Liu-Brennan D, Rimmer J, Allman M, Pang D, Armour C, Woolcock AJ.

Eur Respir J. 1998 Feb;11(2):361-5.

36.

'Normal' lung function in rural Australian aborigines.

Veale AJ, Peat JK, Salome CM, Woolcock AJ, Thompson JE.

Aust N Z J Med. 1997 Oct;27(5):543-9.

PMID:
9404585
37.

Asthma in adults.

Jenkins CR, Woolcock AJ.

Med J Aust. 1997 Aug 4;167(3):160-5. No abstract available.

PMID:
9269272
38.

Learning from asthma deaths.

Woolcock AJ.

BMJ. 1997 May 17;314(7092):1427-8. No abstract available.

39.

Accuracy of asthma treatment in schoolchildren in NSW, Australia.

Paterson NA, Peat JK, Mellis CM, Xuan W, Woolcock AJ.

Eur Respir J. 1997 Mar;10(3):658-64.

40.

Effect of regular inhaled salbutamol on airway responsiveness and airway inflammation in rhinitic non-asthmatic subjects.

Evans DW, Salome CM, King GG, Rimmer SJ, Seale JP, Woolcock AJ.

Thorax. 1997 Feb;52(2):136-42.

41.

Airway closure measured by a technegas bolus and SPECT.

King GG, Eberl S, Salome CM, Meikle SR, Woolcock AJ.

Am J Respir Crit Care Med. 1997 Feb;155(2):682-8.

PMID:
9032213
42.

Evidence for the increase in asthma worldwide.

Woolcock AJ, Peat JK.

Ciba Found Symp. 1997;206:122-34; discussion 134-9, 157-9. Review.

PMID:
9257009
43.

Comparison of three definitions of asthma: a longitudinal perspective.

Toelle BG, Peat JK, van den Berg RH, Dermand J, Woolcock AJ.

J Asthma. 1997;34(2):161-7.

PMID:
9088303
44.

Airway responsiveness in asthma: bronchial challenge with histamine and 4.5% sodium chloride before and after budesonide.

du Toit JI, Anderson SD, Jenkins CR, Woolcock AJ, Rodwell LT.

Allergy Asthma Proc. 1997 Jan-Feb;18(1):7-14.

PMID:
9066830
45.

Serum IgE levels, atopy, and asthma in young adults: results from a longitudinal cohort study.

Peat JK, Toelle BG, Dermand J, van den Berg R, Britton WJ, Woolcock AJ.

Allergy. 1996 Nov;51(11):804-10.

PMID:
8947338
46.

Asthma--disease of a modern lifestyle.

Woolcock AJ.

Med J Aust. 1996 Oct 7;165(7):358-9. No abstract available.

PMID:
8890840
47.

Asthma and atopy in four rural Australian aboriginal communities.

Veale AJ, Peat JK, Tovey ER, Salome CM, Thompson JE, Woolcock AJ.

Med J Aust. 1996 Aug 19;165(4):192-6. Erratum in: Med J Aust 1996 Sep 16;165(6):308.

PMID:
8773647
48.

Corticosteroid-resistant asthma. Definitions.

Woolcock AJ.

Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 2):S45-8. No abstract available.

PMID:
8756787
49.

Strategies for the management of asthma.

Woolcock AJ.

Respirology. 1996 Jun;1(2):79-83. Review.

PMID:
9434322
50.

How does inflammation cause symptoms?

Woolcock AJ.

Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 2):S21-2. Review. No abstract available.

PMID:
8646378

Supplemental Content

Loading ...
Support Center